logo
Plus   Neg
Share
Email

Rio Tinto, AB InBev Partner To Deliver More Sustainable Aluminium Beer Cans

Rio Tinto Plc. (RTPPF.PK,RIO.L,RIO,RTNTF.PK) and Anheuser-Busch InBev have formed a partnership to deliver a new standard of sustainable aluminium cans, Rio Tinto said in a statement.

The companies have signed a memorandum of understanding committing to work with supply chain partners to bring AB InBev products to market in cans made from low-carbon aluminium. The partnership initially focuses in North America.

AB InBev will use Rio Tinto's low-carbon aluminium made with renewable hydropower along with recycled content to produce a more sustainable beer can. This will offer a potential reduction in carbon emissions of more than 30 percent per can compared to similar cans produced today using traditional manufacturing techniques in North America.

The first 1 million cans produced through the partnership will be piloted in the United States on Michelob ULTRA, Rio Tinto said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. tech giant Google is laying the groundwork for a fiber-optic network that will connect the first time through Saudi Arabia and Israel, opening a new global internet traffic corridor, the Wall Street Journal reported, citing people familiar with the plans. The link would be established as part of an optical-fiber cable line connecting Europe with India. U.S. retailers Best Buy Co. Inc., Abercrombie & Fitch Co., and Dollar Tree Inc. on Tuesday reported results for the third quarter that surpassed analysts' expectations. The upbeat results indicate that retailers have largely recovered from the impact of the coronavirus pandemic just as the holiday season approaches. The companies have also intensified their focused on digital sales. The U.S. Food and Drug Administration approved the first drug to treat primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder which causes recurrent kidney stones and loss of kidney function. Alnylam Pharmaceuticals' Oxlumo (lumasiran) in the form of injection lowers urinary oxalate levels in pediatric and adult patients.
Follow RTT